News Corporation filed a Form 8-K with the SEC on September 23, 2026, reporting its required daily disclosure to the Australian Securities Exchange of transactions conducted under the company's stock repurchase program.
Northwest Natural Holding Company filed a Form 8-K with the SEC on September 23, 2026, disclosing a settlement in the Texas general rate case involving its wholly owned indirect subsidiaries SiEnergy Gas, LLC, Pines Gas, Inc., and Pines Gas Development, Inc.
Millrose Properties, Inc. filed a Form 8-K with the SEC on September 22, 2026, disclosing the pricing of a $1,000,000,000 private senior notes offering structured in two equal tranches with maturities in 2029 and 2031.
Apimeds Pharmaceuticals US, Inc. filed a Form 8-K on September 23, 2026, disclosing that a 1-for-10 reverse stock split of its common stock became effective at 12:01 a.m. Eastern Time on July 24, 2026, following a Certificate of Amendment filed with the Delaware Secretary …
Boston Scientific Corporation filed an 8-K on September 23, 2026, disclosing that Executive Vice President and Group President Arthur C. Butcher has informed the company of his decision to retire, with an effective retirement date of January 1, 2027.
Ispire Technology Inc. filed a Form 8-K with the SEC on September 22, 2026, disclosing the publication of an updated investor presentation under Regulation FD.
Royal Caribbean Cruises Ltd. filed an 8-K with the SEC on September 23, 2026, disclosing that it has entered into definitive agreements to acquire a 50% equity interest in the business comprising the Sandals and Beaches Resorts for a base purchase price of approximately …
Angi Inc. filed an 8-K with the SEC on September 23, 2026, reporting that Jeffrey W. Kip departed as Chief Executive Officer and board member effective September 22, 2026, and that Michael Steib was appointed to succeed him as CEO on the same date.
Ionis Pharmaceuticals, Inc. filed a Form 8-K with the SEC on September 23, 2026, disclosing positive prespecified interim results from the ongoing Phase 3 IMAgINATION study evaluating investigational sefaxersen in adults with primary IgA nephropathy.
Ivanhoe Electric Inc. filed an 8-K with the SEC on September 23, 2026, disclosing the release of an updated Preliminary Feasibility Study and Technical Report Summary for its Santa Cruz Copper Project in Arizona, prepared in accordance with SEC S-K 1300 regulations by multiple …